Registry of Lobbyists

Registration - In-house Organization

Innovative Medicines Canada / Médicaments novateurs Canada / David Renwick, Interim President

Registration Information

In-house Organization name: Innovative Medicines Canada / Médicaments novateurs Canada
Previous in-house organization names
Responsible Officer Name: David Renwick, Interim President 
Responsible Officer Change History
Initial registration start date: 2004-08-19
Registration status: Active
Registration Number: 956428-371

Associated Communications

Total Number of Communication Reports: 913

Monthly communication reports in the last 6 months: 37

Version 2 of 108 (2005-04-26 to 2005-09-19)

Version 2 of 108 (2005-04-26 to 2005-09-19) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Organization Information

Organization: RX&D
55 METCALFE STREET, SUITE 1220
OTTAWA, ON  K1P 6L5
Canada
Telephone number: 613-236-0455
Fax number: 613-236-6756  
Responsible officer name and position during the period of this registration: RUSSELL WILLIAMS, PRESIDENT  
 
Description of the organization's activities: CANADA'S RESEARCH-BASED PHARMACEUTICAL INDUSTRY (RX&D) IS THE ASSOCIATION OF CANADA'S RESEARCH-BASED PHARMACEUTICAL INDUSTRY. THE COMPANIES THAT MAKE UP THE MEMBERSHIP OF RX&D ARE ENGAGED IN THE RESEARCH AND DEVELOPMENT, PRODUCTION, MARKETING, AND SERVICING OF PRESCRIPTION AND PROFESSIONAL NON-PRESCRIPTION PHARMACEUTICALS. RX&D MEMBERS EMPLOY MORE THAN 23,000 PEOPLE ACROSS CANADA. COMPRISED OF COMPANIES OF ALL SIZED, RX&D MEMBERSHIP REFLECTS THE INTERNATIONAL SCOPE OF TODAY'S MODERN PHARMACEUTICAL INDUSTRY AND INCLUDES THE CANADIAN OPERATIONS OF DOMESTIC FIRMS. AS WELL AS THOSE WITH HEADQUARTERS IN OTHER COUNTRIES, RX&D MEMBERSHIP IS CURRENTLY MADE UP OF 53 MEMBER COMPANIES.
Organization's membership or classes of membership: FULL MEMBERS-CORPORATE PARTNERSHIPS, FIRMS AND CORPORATIONS OR SUBSIDIARIES WHO REASEACH, DEVELOP, MANUFACTURE AND/OR DISTRIBUTE BRAND NAME PHARMACEUTICALS. RESEARCH ASSOCIATE MEMBERS - CORPORATE PARTNERSHIPS, FIRMS AND CORPORATIONS OR SUBSIDIARIES WHO ARE ENGAGED FOR PROFIT IN RESEARCH AND DEVELOPMENT OF PHARMACEUTICAL PRODUCTS. MANUFACTURING AFFILIATE MEMBERSHIP - CORPORATE PARTNERSHIPS, FIRMS AND CORPORATIONS OR SUBSIDIARIES WHO ARE ENGAGED IN CUSTOM MANUFACTURING OR CUSTOM PACKAGING, FOR OR SUPPLY PHARMACEUTICAL CHEMICALS TO FULL MEMBERS.
 
Was the organization funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbyists Employed by the Organization

Name: MARC DESMARAIS
Position title: V-P FEDERAL GOVERNMENT AFFAIRS
Public offices held: Yes
 
Name: MARC DESMARAIS
Position title: V-P FEDERAL GOVERNMENT AFFAIRS
Public offices held: Yes
 
Name: JULIE LATRÉMOUILLE
Position title: DIRECTOR, REGULATORY AFFAIRS
Public offices held: N/A. Disclosure of this information was not a requirement prior to June 20, 2005.
 
Name: JACQUES LEFEBVRE
Position title: V-P, COMMUNICATIONS
Public offices held: N/A. Disclosure of this information was not a requirement prior to June 20, 2005.
 
Name: BRIGITTE NOLET
Position title: V-P, POLICY, RESEARCH AND SCIENTIFIC AFFAIRS
Public offices held: N/A. Disclosure of this information was not a requirement prior to June 20, 2005.
 
Name: BENOIT VIOLETTE
Position title: SENIOR ADVISOR, FEDERAL GOVERNMENT AFFAIRS
Public offices held: N/A. Disclosure of this information was not a requirement prior to June 20, 2005.
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Aboriginal Affairs and Northern Development Canada, Agriculture and Agri-Food Canada (AAFC), Atlantic Canada Opportunities Agency (ACOA), Canadian International Development Agency (CIDA), Canadian International Trade Tribunal (CITT), Citizenship and Immigration Canada, Environment Canada, Federal Office of Regional Development – Quebec (FORD[Q]), Finance Canada (FIN), Fisheries and Oceans Canada (DFO), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Human Resources Development Canada (HRDC), Industry Canada, Justice Canada (JC), National Defence (DND), Natural Resources Canada (NRCan), Patented Medicine Prices Review Board (PMPRB), Privy Council Office (PCO), Public Works and Government Services Canada, Revenue Canada (RC), Solicitor General Canada (SGC), Statistics Canada (StatCan), Transport Canada (TC), Treasury Board Of Canada Secretariat (TBS), Veterans Affairs Canada (VAC), Western Economic Diversification Canada (WD)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Grass-roots communication, Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Aboriginal Affairs, Agriculture, Constitutional Issues, Consumer Issues, Defence, Education, Employment and Training, Energy, Environment, Financial Institutions, Fisheries, Forestry, Government Procurement, Health, Immigration, Industry, Infrastructure, Intellectual Property, Internal Trade, International Relations, International Trade, Justice and Law Enforcement, Labour, Regional Development, Science and Technology, Small Business, Sports, Taxation and Finance, Telecommunications, Tourism, Transportation
 
Subject Matter: Retrospective: INDUSTRY CANADA: POLITICAL/BUREAUCRAT, INNOVATION STRATEGYPM(NOC)REGULATIONS: CROSS-BORDER TRADE; BUDGET, ISSUES AFFECTING HEALTH AND PHARMACEUTICAL INDUSTRY, BIOTECHNOLOGY.HEALTH CANADA: INNOVATION STRATEGY.PM(NOC) REGULATIONS: CROSS-BORDER TRADE; DRUG SAFETY; PUBLIC HEALTH.FOREIGH AFFAIRS: POLITICAL, PROPOSAL CHANGES TO PM(NOC); CORSS-BORDER TRADE, INTERNATIONAL, AID PROGRAMSENVIRONMENT CANADA: POLITICAL, ISSUES AFFECTING PHARMACEUTICALS; PM(NOC) REGULATIONS
Subject Matter: Prospective: TREASURY BOARD: SMART REGULATIONSHEALTH: DRUG SAFETY, INNOVATION ISSUES; CROSS BORDER TRADE; DRUG APPROVAL NPS ETC.IND. CAN: INNOVATION ISSUES, PN (NOC) REGULATIONS; PHARMACEUTICAL RX&D ISSUES, SMART REGULATIONS.FOREIGH AFFAIRS & INTERNATIONAL TRADE: ON GOING INTERNATIONAL ISSUES